KB Partners

entrepreneurs for entrepreneurs

{title}

Venture Funds I & II > News

June 30, 2009

Accumetrics, Inc. announces that it has reached the halfway mark (1,600 patients) in the enrollment of its landmark clinical trial, GRAVITAS (Gauging Responsiveness with A VerifyNow Assay Impact on Thrombosis And Safety).